US jan/san manufacturer GOJO responded swiftly to a warning letter from the US Food and Drug Administration (FDA) in January.…
To continue reading this article, you must have a Basic Membership or higher.
Existing subscribers, please log in with your email address to link your account access.
New Subscribers please see subscription options below
Basic membership
Digital membership
Premium membership
VIP membership
Basic membership
FREE
As a Basic member you will receive:
- Partial access to OPI.net content – you will not have access to premium content
- Access to Blogs
- Videos
- Daily news email
- Online directory access
- Whitepapers
- Supplements
- OP Confidence Surveys
Digital membership
£100/$150* Annual
In addition to the Basic membership you will also receive:
- Access to all OPI.net content
- OPI in App form
Premium membership
£199/$299* Annual
In addition to the Digital membership you will also receive:
- OPI magazine in print
- Research summaries
- 10% discount on all OPI events and research reports
VIP membership
£650/$999* Annual
In addition to the Premium membership you will also receive:
- Exclusive invites to OPI-VIP Executive lunches and dinners
- Priority breaking news alerts
- Exclusive access to a quarterly focus group or roundtable discussion
- Invitation to join the OPI CEO Forum group on LinkedIn
- Personalised assistance to effect introductions to key contacts in the OPI database
- 15% discount on selected OPI products including advertising, research, recruitment and training
- Dedicated account manager
